<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03120026</url>
  </required_header>
  <id_info>
    <org_study_id>20170011726</org_study_id>
    <nct_id>NCT03120026</nct_id>
  </id_info>
  <brief_title>Improving Rehabilitation In Sarcopenia (IRIS)</brief_title>
  <acronym>IRIS</acronym>
  <official_title>A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Sarcopenia in Older Adults Undergoing Physical Rehabilitation the IRIS (Improving Rehabilitation In Sarcopenia) Study: a Randomized, Double-blind, Placebo-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda di Servizi alla Persona di Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda di Servizi alla Persona di Pavia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, double-blind, placebo-controlled supplementation trial tested the hypothesis
      that nutritional supplementation with muscle-target nutritional supplementation concurrent
      with regular, controlled physical activity would increase the efficacy of physical
      rehabilitation in old adults suffering from sarcopenia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized, double-blind, placebo-controlled supplementation trial tested the hypothesis
      that nutritional supplementation with whey protein, essential amino acids - mainly leucine -
      vitamin D and calcium concurrent with regular, controlled physical activity would increase
      the efficacy of physical rehabilitation in old adults suffering from sarcopenia
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2017</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gait speed</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in gait speed (4-meter walking test)/month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical performance - Tinetti</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in Tinetti scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical performance - Timed Up and Go test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in timed up and go test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical performance - chair-stand</measure>
    <time_frame>8 weeks</time_frame>
    <description>chair-stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status - Barthel</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in Barthel index score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status - ADL</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in activities of daily living (ADL) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status - handgrip strength</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in handgrip strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in body weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle mass</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in appendicular muscle mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function - trail making test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in trail making test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function - Mini Mental State Examination</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in Mini Mental State Examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in 12-item Short-Form Health Survey score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs</measure>
    <time_frame>8 weeks</time_frame>
    <description>Difference in costs of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>8 weeks</time_frame>
    <description>Difference in rate of adverse events related to gastrointestinal intolerance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Experimental Product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two servings (40 grams each) of powder (Fortifit; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isocaloric Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two servings (40 grams each) of an isocaloric (maltodextrins) powder which has to be dissolved in 125 ml of water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Experimental product</intervention_name>
    <description>Two servings (40 grams each) of powder (Fortifit; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.</description>
    <arm_group_label>Experimental Product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Isocaloric placebo</intervention_name>
    <description>Two servings (40 grams each) of an isocaloric (maltodextrins) powder which has to be dissolved in 125 ml of water.</description>
    <arm_group_label>Isocaloric Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 65 years or older

          -  admission for physical rehabilitation

          -  sarcopenia, measured with bioelectrical impedance assessment (BIA) + handgrip strength
             and gait speed

          -  Mini Mental State Examination ≥18

          -  Informed consent

        Exclusion Criteria:

          -  Any malignant disease during the last five years

          -  Known kidney failure (previous glomerular filtration rate &lt;30 ml/min);

          -  Known liver failure (Child B or C)

          -  Psychiatric disease

          -  Endocrine disorders associated with disorders of calcium metabolism (excluding
             osteoporosis)

          -  Indications related to the study product:

        More than 10 µg (400 IU) of daily Vitamin D intake from medical sources More than 500 mg of
        daily calcium intake from medical sources. Adherence to a high energy or high protein diet
        up or use of protein containing or amino acid containing nutritional supplements up to
        three months before starting the study.

          -  Known allergy to milk, milk products or other components of the proposed interventions

          -  Indication to or ongoing artificial nutrition support

          -  Inclusion in other nutrition intervention trials

          -  Investigator's uncertainty about the willingness or ability of the subject to comply
             with the protocol requirements

          -  Refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariangela Rondanelli, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Azienda di Servizi alla Persona di Pavia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariangela Rondanelli, MD, PhD</last_name>
    <phone>0039-0382381749</phone>
    <email>mariangela.rondanelli@unipv.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Geriatric physical medicine and rehabilitation division at the Istituto Santa Margherita - Azienda di Servizi alla Persona di Pavia</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariangela Rondanelli</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geriatric physical medicine and rehabilitation division at the Istituto Santa Margherita, Azienda di Servizi alla Persona di Pavia</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mariangela Rondanelli, MD, PhD</last_name>
      <phone>0039-0382381749</phone>
      <email>mariangela.rondanelli@unipv.it</email>
    </contact>
    <investigator>
      <last_name>Fabio Guerriero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2017</study_first_posted>
  <last_update_submitted>March 25, 2018</last_update_submitted>
  <last_update_submitted_qc>March 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda di Servizi alla Persona di Pavia</investigator_affiliation>
    <investigator_full_name>Mariangela Rondanelli</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

